Natera wins 30% ongoing royalty in MRD patent dispute with ArcherDx, Invitae

Reuters04-09
Natera wins 30% ongoing royalty in MRD patent dispute with ArcherDx, Invitae
  • Delaware federal judge set 30% ongoing royalty to Natera on post-injunction revenue from infringing MRD-related product sales that qualify for exceptions to injunction.
  • Ruling issued April 6, 2026; injunction entered Nov. 21, 2023.
  • Jury’s effective 20.5% royalty on pre-injunction MRD revenue remains unchanged.
  • Court upheld validity of three asserted MRD patents in Natera litigation against ArcherDx, Invitae.
  • Verdict finding patent validity, direct infringement for non-MRD products remains intact.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Natera Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202604090600BIZWIRE_USPR_____20260409_BW795411) on April 09, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment